RES-ELUTION-III

Trial Profile

RES-ELUTION-III

Planning
Phase of Trial: Phase III

Latest Information Update: 12 Nov 2008

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Coronary artery disease; Coronary artery restenosis
  • Focus Therapeutic Use
  • Acronyms RES-ELUTION-III
  • Sponsors Conor Medsystems; Cordis Corporation
  • Most Recent Events

    • 12 Nov 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top